Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga-68 P16-093 PET/CT in Prostate Cancer
NCT03444844Phase 2Active, not recruiting
- Sponsor
- Five Eleven Pharma, Inc.
- Start
- May 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-P16-093 in prostate cancer (PCa), sponsored by Five Eleven Pharma, Inc.. Started May 2018; status: active, not recruiting.
02
Drugs
68Ga-P16-093
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03444844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03444844.